Diabetes Patients Shielded From Rising Insulin Prices?
For many patients on insulin, the necessary costs go beyond test strips, lancets, and syringes to include durable medical equipment for insulin pumps (infusion sets, reservoirs, and pods); continuous glucose monitoring devices (sensors, transmitters, and receivers); glucagon in case of a hypoglycemic emergency; glucose tablets or glucose gel; and ketone test strips for early detection of ketosis.Source: Medpage Today
New Insight Into the Biology of Insulin Release
In a new study, Yale researchers challenge a long-held assumption about how insulin-producing cells in the pancreas sense and respond to glucose. Their findings could lead to changes in the way that scientists approach the treatment of diabetes, the authors said.
Yale-led Study Reveals Biology of Leptin, the Hunger Hormone
In a new study, Yale researchers offer insight into leptin, a hormone that plays a key role in appetite, overeating, and obesity. Their findings advance knowledge about leptin and weight gain, and also suggest a potential strategy for developing future weight-loss treatments, they said.
Immunotherapy Delays Type 1 Diabetes in People at High Risk
A drug that targets the immune system can delay the onset of type 1 diabetes in people at high risk of developing the disease, said a Yale investigator who led the National Institutes of Health-funded Diabetes TrialNet study. The research is the first to show that the progression of type 1 diabetes can be slowed by two or more years with immunotherapy.
Diabetics rationing insulin amid rising drug prices
Drug manufacturers were grilled Wednesday about the skyrocketing price of insulin, which has doubled in the last five years and led some patients to ration the life-saving drug. One study finds the underuse of insulin could affect nearly 40 million people with diabetes by 2030.Source: CBS News
Yale Expert Testifies in Washington on the Harm Caused by Soaring Insulin Prices
On April 2, Kasia Lipska, MD, MPH, assistant professor of medicine (endocrinology), testified in Washington before the House Committee on Energy & Commerce Oversight and Investigations Subcommittee on the severe harm that high insulin prices does to patients, including her own.
Insulin Pump Changes Diabetes Treatment
Like many discoveries, the development of the first insulin pump was a combination of ingenuity and teamwork. In 1979, Yale doctors were conducting studies to figure out the best way to deliver insulin to children who suffer from diabetes. They discovered that giving small amounts continuously with larger doses at meals worked better than giving one large dose, because the smaller doses more closely resemble the way the pancreas produces insulin.
Rachel Perry Receives the Yale Cancer Center Translational Science Research Prize
Congratulations to the Endocrinology section's Rachel Perry, who received the Yale Cancer Center Translational Science Research Prize, for a paper published in Cell Reports this summer that showed that both mitochondrial uncoupling with a controlled-release mitochondrial protonophore (CRMP) her team developed several years ago (Perry et al. Science 2015), and glucose-lowering with metformin, slowed obesity-associated tumor growth in two mouse models of colon cancer in an insulin-dependent manner.
Dr. Gerald Shulman wins American Diabetes Association’s highest honor
Dr. Gerald I. Shulman of the Yale School of Medicine has won the 2018 Banting Medal for Scientific Achievement, the highest honor of the American Diabetes Association (ADA). Shulman will be recognized for this honor and deliver his Banting Medal Lecture, “Mechanisms of Insulin Resistance: Implications for Obesity, Lipodystrophy and Type 2 Diabetes,” at the ADA’s 78th Scientific Sessions in Orlando, Florida, June 22-26.
New biomarkers help predict outcomes in diabetic kidney disease
A common complication of type 2 diabetes occurs when filters within the kidney are damaged, leading to an abnormal buildup of protein in urine and a decline in kidney function. This condition, called diabetic kidney disease, can lead to irreversible kidney failure that is currently difficult to predict. A team of researchers led by professor of medicine Dr. Chirag Parikh in collaboration a group at Icahn School of Health at Mount Sinai has recently made strides that could lead to improved diagnostics and treatment plans for this condition.
Yale investigators join alliance to advance research on obesity and diabetes
Yale researchers have partnered with investigators at leading research institutions in Connecticut, and with a prestigious counterpart in Israel, to fill a research void in the field of metabolic diseases, which affect billions of people worldwide.
Yale Investigator Recognized for Impact on Clinical Practice
Robert S. Sherwin, MD, CNH Long Professor of Medicine, has received the Edward H. Ahrens, Jr. Distinguished Investigator Award from the Association for Clinical and Translational Science (ACTS) for decades of research that has had far-reaching effects on our understanding and treatment of diabetes.
Endocrinologist Robert Sherwin, M.D., FW '74, receives Naomi Berrie Award for hypoglycemia research
Robert S. Sherwin, M.D., FW '74, professor of endocrinology, received the 17th Naomi Berrie Award for his work on understanding how the brain responds to hypoglycemia. Sherwin was recognized AT a ceremony at the Frontiers in Diabetes Conference held at the Naomi Berrie Diabetes Center last weekend. The prize is Columbia University's top honor for excellence in diabetes research.